Oxford Gene Technology company

Oxford Gene Technology (OGT) provides world-class genetics research solutions to leading clinical and academic research institutions.
Founded by Professor Sir Edwin Southern, OGT has helped pioneer the molecular medicine revolution by enabling smarter decision making in human healthcare. With customers in over 60 countries worldwide and ambitious expansion plans, OGT has a strong reputation and increasing share in the large and growing genomic medicine market.
OGT is a rapidly growing company with state-of-the-art facilities and over 100 employees based at our head-office in Begbroke, Oxfordshire, or at our Cytocell office in Cambridge, Cambridgeshire. Since its acquisition in 2017, OGT are a subsidiary of the highly successful Sysmex Corporation, currently ranked in the top 10 global in‐vitro diagnostic companies.
Technology: P4 Medicine
Industry: Personalized Medicine
Headquarters: Bugbrooke, Northamptonshire, United Kingdom
Founded Date: 1995
Employees Number: 101-250
Funding Status: M&A

Visit Website
Register and Claim Ownership